In a push for better patient safety and superior components in pharmaceutical packaging, SCHOTT is extending the range of its extractables and leachables (E&Ls) laboratory services to better ensure that the interaction between drugs and pharmaceutical packaging materials do not cause safety risks. SCHOTT’s capabilities will be on display at Interphex in New York City on April 23 to 25 at booth 3522.
E&Ls are substances that can be dissolved and released from the glass, metals, rubber, lubricants, and adhesives of pharmaceutical packaging materials. To determine any possible interactions between these materials and the drugs and prevent these reactions, drug manufacturers are obliged to perform extensive studies. SCHOTT’s extended service offering more efficiently assesses risks to better support pharmaceutical companies in avoiding interactions between drugs and packaging.
SCHOTT Pharma Services (schott.com) is an experienced partner for pharmaceutical manufacturers, who benefit not only from SCHOTT’s decades of expertise but also from a unique combination of laboratory services for delamination, E&L, and stability tests.
As early as 1911, the SCHOTT group started to produce pharmaceutical containers made of glass and eventually added ampoules, vials, cartridges, and syringes to its pharmaceutical packaging lineup. The company has built up comprehensive product and process know-how and maintains a basic research center for glass. The SCHOTT Pharma Services’ know-how and professional skills have been helping enterprises ensure the safety of the customer’s medicines since 2009.
“An increasing number of drug manufacturers ask us to test their outer packages for everything from the analysis of interactions between drug and packaging materials to fracture and strength tests,” said Daniel Haines, Scientific Advisor, at SCHOTT Pharma Services. “We’re dedicated to continual investments in technology and research that advance our knowledge of and ensure the integrity of pharma packaging and, more importantly, the health of patients.”